Showing results (1371-1380 of 4,425) with videos related to
Sort By:
Pageof 443
Cancer Cell International|September 8, 2016
Molecular mechanism leading to SAHA-induced autophagy in tumor cells: evidence for a p53-dependent pathwayLeopold F Fröhlich, Maria Mrakovcic, Claudia Smole, et al.Cancer Cell International|June 2, 2018
APOBEC3B up-regulation independently predicts ovarian cancer prognosis: a cohort studyYan Du, Xiang Tao, Jing Wu, et al.Cancer Cell International|March 5, 2009
Intrinsic anticarcinogenic effects of Piper sarmentosum ethanolic extract on a human hepatoma cell lineShahrul Hisham Zainal Ariffin, Wan Haifa Haryani Wan Omar, Zaidah Zainal Ariffin, et al.Cancer Cell International|June 2, 2009
Bioluminescence imaging reveals inhibition of tumor cell proliferation by Alzheimer's amyloid beta proteinHong Zhao, Jinmin Zhu, Kemi Cui, et al.Cancer Cell International|January 9, 2009
Inhibition of PI3K increases oxaliplatin sensitivity in cholangiocarcinoma cellsKawin Leelawat, Siriluck Narong, Wandee Udomchaiprasertkul, et al.Cancer Cell International|November 16, 2007
In vitro characterization and inhibition of the CXCR4/CXCL12 chemokine axis in human uveal melanoma cell linesSebastian Di Cesare, Jean-Claude Marshall, Bruno F Fernandes, et al.Cancer Cell International|November 28, 2006
Expression of EpCAM in uveal melanomaDanilo N Odashiro, Alexandre N Odashiro, Patrícia R Pereira, et al.Cancer Cell International|November 19, 2008
Preclinical evaluation of the antineoplastic action of 5-aza-2'-deoxycytidine and different histone deacetylase inhibitors on human Ewing's sarcoma cellsAnnie Hurtubise, Mark L Bernstein, Richard L MomparlerCancer Cell International|April 21, 2009
Pegylated derivatives of recombinant human arginase (rhArg1) for sustained in vivo activity in cancer therapy: preparation, characterization and analysis of their pharmacodynamics in vivo and in vitro and action upon hepatocellular carcinoma cell (HCC)Sam-Mui Tsui, Wai-Man Lam, Tin-Lun Lam, et al.Cancer Cell International|February 20, 2009
A reason why the ERBB2 gene is amplified and not mutated in breast cancerDaniel Birnbaum, Fabrice Sircoulomb, Jean ImbertPageof 443